Document:

EX-10.3 JOINT DEVELOPMENT AGREEMENT

 

EXHIBIT 10.3

	 	 	 	 	 
	 

	 	 	 	CONFORMED COPY

JOINT DEVELOPMENT AGREEMENT

     THIS JOINT DEVELOPMENT AGREEMENT (this “Agreement”) is made and entered into as of
January 31, 2006 (the “Effective Date”) by and between Emdeon Corporation, a Delaware corporation,
and Emdeon Practice Services, Inc. (collectively, “Emdeon”) and WebMD Health Corp., a Delaware
corporation (the “Company”).

RECITALS

     WHEREAS, Emdeon offers an Electronic Medical Record product (the “EMR Product”) to physician
practices; and

     WHEREAS, the Company provides a Personal Health Record product (the “PHR Product”) to its
clients, their eligible employees and their dependents.

     WHEREAS, the Company and the Emdeon desire to identify potential joint development
opportunities regarding these product areas.

     NOW, THEREFORE, in consideration of the mutual covenants set forth in this Agreement and other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto agree as follows:

AGREEMENT

                    SECTION 1. Joint Development 

     (a)           Within thirty (30) days of the execution of this Agreement, Emdeon and the Company shall
create a joint task force (the “Joint Task Force”) to explore potential opportunities for
leveraging Emdeon assets in the area of EMR Products and the Company’s assets in the areas PHR
Products. Within ninety (90) days of the execution of this Agreement, the parties will seek to
agree to an integration plan (which complies with applicable law and privacy and security
requirements) for integrating the PHR Product and the EMR Product so as to enable patients and
physicians to communicate more effectively (the “Integration Plan”). The parties will work to
attempt to integrate the Company’s PHR with Emdeon’s clinical products to allow users of PHR
services to import information from the EMR, and to allow Practice Service users to import
information from the Company’s PHR. To the extent that Emdeon Practice Services, Inc. desires to
integrate its product with a PHR, Practice Services agrees to do so through the Company.

     (b)           As between Emdeon and the Company, each party will be responsible for funding its own
organization’s development requirements and implementation costs for its portion of the Data
Integration Plan and the Joint Task Force.

 

 

                    SECTION 2.Ownership/TradeMarks/ServiceMarks 

     (a)           As between the Company and Emdeon, each party retains all its right, title and interest in
each of its products. Nothing in this Agreement shall limit or restrict in any way either party
hereto from engaging in any business activities or developing any products, except that each party
shall be bound by its confidentiality obligations contained herein as they relate to Confidential
Information.

     (b)           Subject to the terms and conditions of this Agreement, Company hereby grants to Emdeon a
non-exclusive worldwide right and license to use the trade names, trademarks, logos and service
marks owned by the Company (and/or the Company’s suppliers, subsidiaries or affiliates, as
applicable) (the “Company Marks”) in the form provided to Emdeon by the Company solely for use in
marketing activities and solely to the extent necessary to perform Emdeon’s obligations under this
Agreement. Title to and ownership of all the Company Marks shall remain entirely with the Company
and use of the Company Marks shall be in conformance with applicable trademark usage policies
established by Company and provided to Emdeon from time to time. The license granted by Company to
Emdeon hereunder shall automatically and immediately terminate upon the expiration or termination
of this Agreement except as otherwise set forth herein.

     (c)           Subject to the terms and conditions of this Agreement, Emdeon hereby grants to the Company
a non-exclusive worldwide right and license to use the trade names, trademarks, logos and service
marks owned by Emdeon (and/or Emdeon’s suppliers, subsidiaries or affiliates, as applicable) (the
“Emdeon Marks”) in the form provided to the Company by Emdeon solely for use in marketing
activities and solely to the extent necessary to perform the Company’s obligations under this
Agreement. Title to and ownership of all Emdeon Marks shall remain entirely with Emdeon and use of
the Emdeon Marks shall be in conformance with applicable trademark usage policies established by
Emdeon and provided to the Company from time to time. The license granted by Emdeon to the Company
hereunder shall automatically and immediately terminate upon the expiration or termination of this
Agreement except as otherwise set forth herein.

                    SECTION 3. Term; Termination

     (a)           Initial Term. The term of this Agreement shall commence on Effective Date and
shall remain in effect for a period of five (5) years from the Effective Date, unless sooner
terminated in accordance with the provisions of Section 3(b) or 3(c).

     (b)           Termination for breach. In the event either party materially breaches this
Agreement and fails to cure such breach within ninety (90) days following receipt of written notice
describing in reasonable detail the facts and circumstances concerning the breach, the other party
may terminate this Agreement. Notwithstanding the foregoing, if Emdeon alleges a breach by the
Company of this Agreement and the Company disputes such allegations of breach, Emdeon agrees to
continue to perform its obligations hereunder until such dispute is resolved by the parties or by a
determination through arbitration as provided in Section 5, without prejudice to all remedies
available to the Company.

2

 

          (c)Termination by the Company. At any time during the term of this Agreement,
Company may, in its sole discretion and with or without cause, terminate the Agreement, upon at
least ninety (90) days written notice from the Company.

                    SECTION 4. CONFIDENTIAL INFORMATION

     (a)           “Confidential Information” means any confidential, trade secret or other
proprietary information disclosed by one party to the other under or in connection with this
Agreement, except for information that: (i) is already known to the receiving party without
restriction at the time received from the disclosing party, (ii) is developed by the receiving
party independent of the receiving party’s Confidential Information; (iii) is obtained from a
source other than the disclosing party not known to be subject to an obligation of confidentiality
and without breach of this Agreement; (iv) is in the public domain when received, or thereafter
enters the public domain through no fault of the receiving party; (v) is lawfully required to be
disclosed to any governmental agency or is otherwise required to be disclosed by law, provided
that, before making such disclosure, the receiving party shall give the disclosing party an
adequate opportunity to interpose an objection or take action to assure confidential handling of
such Confidential Information. Confidential Information also includes Individual Information (as
described below).

     (b)           The receiving party shall: (i) not disclose the Confidential Information to any third
party, other than its employees, agents or independent contractors who are bound, in writing, by
similar confidentiality obligations and who have a need to know such Confidential Information, (ii)
not use the Confidential Information in any fashion except for purposes of performing this
Agreement, and (iii) take steps consistent with its protection of its own confidential and
proprietary information (but in no event exercise less than reasonable care) to prevent
unauthorized disclosure of the Confidential Information.

     (c)           In the performance of this Agreement, Emdeon and the Company and their employees,
subcontractors, and other agents may have access to certain Confidential Information of each
other’s respective clients referred to as “Individual Information.” Individual Information
includes, but is not limited to, information which, in coded or uncoded format, in whole or in
part, relates to patient records or any patient identifiable information, dependents or physicians,
including, without limitation, their respective names, addresses, zip codes, social security
numbers, drug or medical claims data, or other personal data.

     (d)           Upon the termination or expiration of this Agreement, the parties shall promptly return or
destroy all Confidential Information of the other and not retain any copies of the Confidential
Information of the other party.

                     SECTION 5. Disclaimers

     (a)           in no event shall the Company or its suppliers or licensors be liable under any theory
of liability, however arising, for any costs of cover or for indirect, special, incidental, or
consequential damages of any kind arising out of this agreement, even if emdeon has been advised of
the possibility of such damages. 

3

 

     (b)           The Company’s aggregate liability for all damages, losses and causes of
action in any way related to this Agreement, whether in contract, tort (including negligence) or
otherwise, either jointly or severally, shall not exceed one million dollars ($1,000,000). This
section reflects an allocation of risk between the parties, is not a penalty, and shall be
exclusive. This section shall apply despite any failure of essential purpose of any limited
warranty or remedy.

     (c)           NEITHER COMPANY NOR EMDEON MAKES ANY REPRESENTATIONS OR WARRANTIES,
EXPRESS OR IMPLIED (A) REGARDING THE USEFULNESS, ACCURACY, COMPLETENESS, FEASIBILITY, RELIABILITY
OR EFFECTIVENESS OF ITS RESPECTIVE SERVICES OR PRODUCTS; OR (B) THE AMOUNT OF SALES THAT MAY BE
GENERATED FROM THE OTHER’S PRODUCTS OR SERVICES. WITHOUT LIMITING THE FOREGOING, NEITHER PARTY
MAKES ANY REPRESENTATIONS THAT THE OTHER’S USE OF ITS PRODUCTS OR SERVICES WILL BE UNINTERRUPTED OR
ERROR FREE. THE EXPRESS WARRANTIES IN SECTION 5(c) ARE IN LIEU OF ALL OTHER WARRANTIES BETWEEN THE
PARTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT, AND SUCH WARRANTIES
ARE HEREBY DISCLAIMED.

                         SECTION 6. Miscellaneous.

     (a)           Specific Performance. The parties hereto agree that irreparable damage would
occur in the event any provision of the Agreement was not performed in accordance with the terms
hereof and that the parties hereto shall be entitled to specific performance of the terms hereof,
in addition to any other remedy at law or in equity.

     (b)           Amendments and Waivers. Any provision of this Agreement may be amended or waived
if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by
the Company and Emdeon or, in the case of a waiver, by the party or parties against whom the waiver
is to be effective.

     (c)           No waiver. No failure or delay by any party in exercising any right, power or
privilege hereunder (other than a failure or delay beyond a period of time specified herein) shall
operate as a waiver thereof and no single or partial exercise thereof shall preclude any other or
further exercise thereof or the exercise of any other right, power or privilege.

     (d)           Notice Generally. All notices, requests, claims, demands and other communications
hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon
receipt) by delivery in person, by courier service, by fax or by registered or certified mail
(postage prepaid, return receipt requested) to the respective parties at the following
addresses (or at such other address for a party as shall be specified by notice given in
accordance with this Section 6(d)):

4

 

	 	 	 
	 

	 	If to Emdeon:
	 
	 	 
	 
	 	 
	 

	 	Emdeon Corporation
	 

	 	Emdeon Practice Services, Inc.
	 

	 	699 River Drive Center 2,
	 

	 	Elmwood Park, NJ 07407
	 

	 	Attn: General Counsel
	 
	 	 
	 
	 	 
	 

	 	If to the Company:
	 
	 	 
	 
	 	 
	 

	 	WebMD Health Corp.
	 

	 	111 Eighth Avenue
	 

	 	New York, NY 10011
	 

	 	Attn: General Counsel

or at such other address as may be substituted by notice given as herein provided.

               (e)                Successors and Assigns. The obligations of Emdeon in this Agreement shall apply
to Emdeon Corporation and its subsidiary, Emdeon Practice Services, Inc. No party shall assign or
transfer any of its rights or obligations under this Agreement without the prior written consent of
the other parties. This Agreement shall inure to the benefit of and be binding upon the successors
and permitted assigns of the parties hereto as hereinafter provided. In addition, in the event of
any sale, transfer, change of control or other disposition, restructuring or reorganization of
Emdeon Practice Services, Inc. or its business (including by way of stock sale, by sale of all or
substantially all its assets or by any other means or manner or structure) to a third party, such
subsidiary and its business shall continue to be subject to the obligations applicable to its
business under this Agreement. The Agreement shall remain in effect in accordance with its terms
regardless of the percentage ownership, if any, that Emdeon holds of the Company, and regardless
of any sale, transfer, change of control or other disposition, restructuring or reorganization of
Emdeon Corporation or the Company, or either business thereof (including by way of stock sale, by
sale of all or substantially all its assets or by any other means or manner or structure).

     (f)           No Third Party Beneficiaries. No person other than the parties hereto and their
successors and permitted assigns are intended or shall be deemed to be a beneficiary of this
Agreement.

     (g)           Headings. The headings and subheadings in this Agreement are included for
convenience and identification only and are in no way intended to describe, interpret, define or
limit the scope, extent or intent of this Agreement or any provision hereof.

     (h)           Governing Law; Dispute Resolution. This Agreement shall be governed by and
construed in accordance with the laws of the State of New York.

                    (i)           In an effort to resolve informally and amicably any claim or controversy arising out of or
related to this Agreement or the breach, termination, enforcement, interpretation or validity
thereof, each party shall notify the other of any difference or dispute hereunder that

5

 

requires resolution. Emdeon and the Company shall each designate an executive officer to investigate,
discuss and seek to settle the matter between them. If the two are unable to settle the matter
within 30 days after such notification, or such longer time period as they shall agree upon, either
party may initiate final and binding arbitration, in accordance with Paragraph (ii) of this Section
6(h) to resolve such matter, which the parties agree is the sole and exclusive procedure for any
such dispute, except as otherwise provided therein. All offers, promises, negotiations, conduct
and/or statements, whether oral or written, made in the course of the settlement discussions
contemplated by this Paragraph (i) by any of the parties, their agents, employees, experts and/or
attorneys are, and shall be deemed, confidential, and made executed and delivered solely for the
purposes of settlement or compromise, and inadmissible for any purpose, including, without
limitation, impeachment, in any arbitration or other proceeding involving the parties or any third
parties, or in any court or forum whatsoever, provided however that the use of a statement or
information as contemplated in a settlement under this Paragraph (i) that would be admissible or
discoverable shall not be rendered inadmissible or non-discoverable solely as a result of such use.

                    (ii)           The following process shall be followed if, and after, the informal procedures in
Paragraph (i) above do not result in a resolution of the matter. Any dispute, claim or controversy
arising out of or relating to this Agreement or the breach, termination, enforcement,
interpretation or validity thereof, including the determination of the scope or applicability of
this agreement to arbitrate (collectively, a “Claim”), shall be determined by binding arbitration
in New York, New York before three arbitrators. The arbitration shall be administered (including
selection of the arbitrators) by JAMS (www.jamsadr.com) pursuant to its Comprehensive Arbitration
Rules and Procedures. Judgment on the award may be entered in any court having jurisdiction. This
clause shall not preclude parties from seeking provisional remedies in aid of arbitration from a
court of appropriate jurisdiction permitted under the terms of this Section 6(h). In the event of
any Claim under this Agreement or the enforcement of any right under this Agreement by either
party, regardless of whether the Company or Emdeon prevails, Emdeon hereby agrees that Emdeon shall
be responsible for all its own and all of the Company’s costs and expenses relating thereto,
including the reasonable attorneys fees and expenses of Emdeon’s attorneys and other professionals
it may retain and the reasonable fees and expenses of the Company’s attorneys and other
professionals that the Company retains. In addition, the arbitrators will have authority to award
special, punitive, exemplary, consequential, incidental or indirect losses or damages and authority
to award a party, subject to the foregoing sentence regarding Emdeon’s obligation for fees, costs
and expenses, regardless of the prevailing party. The parties hereby agree to submit to the
exclusive personal and subject matter jurisdiction and to the venue of the Supreme Court of the
State of New York, County of New York, for all purposes associated with this Agreement, including
the agreement to arbitrate, enforcing the agreement to arbitrate, and seeking provisional relief
pending award and entering judgment upon the award. Nothing contained in this Section shall
preclude the arbitrators from granting, where appropriate, injunctive or other provisional relief
pending a final award. Notwithstanding the provisions of Section 6, either party may pursue any
provisional remedy (including but limited to preliminary injunctive relief) to either restrain or
mandate certain
conduct in the courts designated in this Section. The parties shall have the right to obtain such
provisional injunctive relief from a court of law designated in this Section pending the
determination and award in the arbitration proceeding. In the event that the Company seeks

6

 

provisional injunctive relief pursuant to this section from the court designated herein, then
Emdeon agrees that it may not request nor may the court require any bond or other security to be
posted by the Company to secure the requested injunctive relief, provided that Emdeon retains any
rights it may have to oppose the injunctive relief on any other grounds. If JAMS is no longer
available or is unwilling to accept the designation provided hereunder, the parties shall mutually
agree upon a substitute professional neutral administrator to replace JAMS.

     (I)           Severability. If any term or other provision of this Agreement is held to be
invalid, illegal or incapable of being enforced by any rule of law, or public policy, all other
conditions and provisions of this Agreement shall nevertheless remain in full force and effect so
long as the economic or legal substance of the transactions is not affected in any manner
materially adverse to any party. Upon a determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the parties as closely as possible in a
mutually acceptable manner in order that the transactions contemplated hereby be consummated as
originally contemplated to the fullest extent possible.

     (j)           Entire Agreement. This Agreement constitutes the entire agreement among the
parties hereto pertaining to the subject matter hereof and supersedes all prior agreements and
understandings pertaining thereto.

     (k)           Independent Contractors. The parties hereto are independent contractors engaged
in the operation of their own respective business. Neither party is, or is to be considered as, the
agent or employee of the other for any purpose whatsoever. Neither party has the authority to enter
into contracts or assume any obligations for the other party or make any warranties or
representations on behalf of the other party. Nothing in this agreement shall be construed to
establish a relationship or joint venturers between the parties.

     (l)           Cumulative Remedies. The rights and remedies provided by this Agreement are
cumulative and the use of any one right or remedy by any party shall not preclude or waive its
right to use any or all other remedies. Said rights and remedies are given in addition to any
other rights the parties may have by law, statute, ordinance or otherwise.

     (m)           Construction. Each party hereto acknowledges and agrees it has had the
opportunity to draft, review and edit the language of this Agreement and that no presumption for or
against any party arising out of drafting all or any part of this Agreement will be applied in any
dispute relating to, in connection with or involving this Agreement. Accordingly, the parties
hereto hereby waive the benefit of any rule of law or any legal decision that would require, in
cases of uncertainty, that the language of a contract should be interpreted most strongly against
the party who drafted such language.

7

 

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.

	 	 	 	 	 
	 	EMDEON CORPORATION

 	 
	 	By:  	/s/ Kevin M. Cameron
 	 
	 	 	Name:  	Kevin M. Cameron 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	EMDEON PRACTICE SERVICES, INC.

 	 
	 	By:  	/s/ Michael Glick
 	 
	 	 	Name:  	Michael Glick 	 
	 	 	Title:  	Senior Vice President 	 
	 
	 	WEBMD HEALTH CORP.

 	 
	 	By:  	/s/ Wayne T. Gattinella
 	 
	 	 	Name:  	Wayne T. Gattinella 	 
	 	 	Title:  	Chief Executive Officer 	 
	 

8<PAGE>
                                                                    Exhibit 10.1

                                    HCA INC.
                        RESTRICTED SHARE AWARD AGREEMENT

     THIS RESTRICTED SHARE AWARD AGREEMENT (this "Agreement") is made and
entered into as of the ___ day of _______, 2006 (the "Grant Date"), between HCA
Inc., a Delaware corporation (the "Company" and, together with its Subsidiaries
and Affiliates, "HCA"), and _____________, (the "Grantee"). Capitalized terms
not otherwise defined herein shall have the meaning ascribed to such terms in
the HCA 2005 Equity Incentive Plan (the "Plan").

     WHEREAS, the Company has adopted the Plan, which permits the issuance of
restricted shares of the Company's common stock, par value $0.01 per share (the
"Common Stock"); and

     WHEREAS, pursuant to the Plan, the Committee has granted an award of
restricted shares to the Grantee as provided herein;

     NOW, THEREFORE, in consideration of the mutual covenants hereinafter set
forth and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto, intending to be legally
bound hereby, agree as follows:

     1. Grant of Restricted Shares.

          (a) The Company hereby grants to the Grantee an award (the "Award") of
_____ shares of Common Stock of the Company (the "Shares" or the "Restricted
Shares") on the terms and conditions set forth in this Agreement and as
otherwise provided in the Plan.

          (b) The Grantee's rights with respect to the Award shall remain
forfeitable at all times prior to the dates on which the restrictions shall
lapse in accordance with Section 3 hereof.

     2. Terms and Rights as a Stockholder.

          (a) Except as provided herein and subject to such other exceptions as
may be determined by the Committee in its discretion, the "Restricted Period"
for Restricted Shares granted herein shall expire as to _________________ of the
Restricted Shares awarded hereunder (as such number maybe adjusted in accordance
with Section 7 hereof) on __________________________________________________.

          (b) The Grantee shall have all rights of a stockholder with respect to
the Restricted Shares, including the right to receive dividends and the right to
vote such Shares, subject to the following restrictions:

<PAGE>

               (i)  the Grantee shall not be entitled to delivery of the stock
                    certificate for any Shares until the expiration of the
                    Restricted Period as to such Shares;

               (ii) none of the Restricted Shares may be sold, assigned,
                    transferred, pledged, hypothecated or otherwise encumbered
                    or disposed of during the Restricted Period as to such
                    Shares; and

               (iii) except as otherwise determined by the Committee at or after
                    the grant of the Award hereunder, any of the Restricted
                    Shares as to which the Restricted Period has not expired
                    shall be forfeited, and all rights of the Grantee to such
                    Shares shall terminate, without further obligation on the
                    part of the Company, unless the Grantee remains in the
                    continuous employment of HCA for the entire Restricted
                    Period relating to such Restricted Shares, as the case may
                    be.

          Any Shares, any other securities of the Company and any other property
(except for cash dividends) distributed with respect to the Restricted Shares
shall be subject to the same restrictions, terms and conditions as such
Restricted Shares.

          (c) Notwithstanding the foregoing, the Restricted Period shall
automatically terminate as to all Restricted Shares awarded hereunder (as to
which such Restricted Period has not previously terminated) upon the occurrence
of the following events:

               (i)  termination of the Grantee's employment with HCA which
                    results from the Grantee's death or Disability; or

               (ii) the occurrence of a Change in Control.

          For purposes of this Agreement, "Disability" means that the Grantee is
permanently unable to perform the essential duties of the Grantee's occupation.

     3. Termination of Restrictions. Upon the expiration or termination of the
Restricted Period as to any portion of the Restricted Shares, or at such earlier
time as may be determined by the Committee, all restrictions set forth in this
Agreement or in the Plan relating to such portion of the Restricted Shares shall
lapse as to such portion of the Restricted Shares, and a stock certificate for
the appropriate number of Shares, free of the restrictions and restrictive stock
legend, shall be delivered to the Grantee or the Grantee's beneficiary or
estate, as the case may be, pursuant to the terms of this Agreement.

     4. Delivery of Shares.

          (a) As of the date hereof, certificates representing the Restricted
Shares shall be registered in the name of the Grantee and held by the Company or

                                      -2-

<PAGE>

transferred to a custodian appointed by the Company for the account of the
Grantee subject to the terms and conditions of the Plan and shall remain in the
custody of the Company or such custodian until their delivery to the Grantee or
Grantee's beneficiary or estate as set forth in Sections 4(b) and (c) hereof or
their reversion to the Company as set forth in Section 2(b) hereof.

          (b) Certificates representing Restricted Shares in respect of which
the Restricted Period has lapsed pursuant to this Agreement shall be delivered
to the Grantee as soon as practicable following the date on which the
restrictions on such Restricted Shares lapse.

          (c) Certificates representing Restricted Shares in respect of which
the Restricted Period lapsed upon the Grantee's death shall be delivered to the
executors or administrators of the Grantee's estate as soon as practicable
following the receipt of proof of the Grantee's death satisfactory to the
Company.

          (d) Each certificate representing Restricted Shares shall bear a
legend in substantially the following form:

          THIS CERTIFICATE AND THE SHARES OF STOCK REPRESENTED HEREBY ARE
          SUBJECT TO THE TERMS AND CONDITIONS (INCLUDING FORFEITURE AND
          RESTRICTIONS AGAINST TRANSFER) CONTAINED IN THE HCA 2005 EQUITY
          INCENTIVE PLAN (THE "PLAN") AND THE RESTRICTED SHARE AWARD AGREEMENT
          (THE "AGREEMENT") BETWEEN THE OWNER OF THE RESTRICTED SHARES
          REPRESENTED HEREBY AND HCA INC. (THE "COMPANY"). THE RELEASE OF SUCH
          SHARES FROM SUCH TERMS AND CONDITIONS SHALL BE MADE ONLY IN ACCORDANCE
          WITH THE PROVISIONS OF THE PLAN AND THE AGREEMENT, COPIES OF WHICH ARE
          ON FILE AT THE COMPANY.

     5. Effect of Lapse of Restrictions. To the extent that the Restricted
Period applicable to any Restricted Shares shall have lapsed, the Grantee may
receive, hold, sell or otherwise dispose of such Shares free and clear of the
restrictions imposed under the Plan and this Agreement.

     6. No Right to Continued Employment. This Agreement shall not be construed
as giving Grantee the right to be retained in the employ of HCA, and, subject to
applicable HCA policies and procedures, HCA may at any time dismiss Grantee from
employment, free from any liability or any claim under the Plan.

     7. Adjustments. The Committee may make adjustments in the terms and
conditions of, and the criteria included in, this Award in recognition of
unusual or nonrecurring events (including, without limitation, the events
described in Section 4.2 of the Plan) affecting HCA, or the financial statements
of HCA, or of changes in applicable

                                      -3-

<PAGE>

laws, regulations, or accounting principles, whenever the Committee determines
that such adjustments are appropriate in order to prevent dilution or
enlargement of the benefits or potential benefits intended to be made available
under the Plan.

     8. Amendment to Award. Subject to the restrictions contained in Section 14
of the Plan, the Committee may waive any conditions or rights under, amend any
terms of, or alter, suspend, discontinue, cancel or terminate, the Award,
prospectively or retroactively; provided that any such waiver, amendment,
alteration, suspension, discontinuance, cancellation or termination which would
adversely affect the rights of the Grantee or any holder or beneficiary of the
Award shall not to that extent be effective without the consent of the Grantee,
holder or beneficiary affected.

     9. Withholding of Taxes. If the Grantee makes an election under section
83(b) of the Code with respect to the Award, the Award made pursuant to this
Agreement shall be conditioned upon the Grantee making prompt payment to the
Company of any applicable withholding obligations or withholding taxes by the
Grantee ("Withholding Taxes"). Failure by the Grantee to pay such Withholding
Taxes will render this Agreement and the Award granted hereunder null and void
ab initio and the Restricted Shares granted hereunder will be immediately
cancelled. If the Grantee does not make an election under section 83(b) of the
Code with respect to the Award, upon the lapse of the Restricted Period with
respect to any portion of the Restricted Shares (or property distributed with
respect thereto), and unless other arrangements are made at the sole discretion
of the Company, the Company shall cancel such Restricted Shares (or withhold
property) having an aggregate Fair Value, on the date next preceding the lapse
of the Restricted Period, in an amount required to satisfy the required
Withholding Taxes as set forth by Internal Revenue Service guidelines for the
employer's minimum statutory withholding with respect to Grantee. The Company
shall deduct from any distribution of cash (whether or not related to the Award
including, without limitation, salary payments) to the Grantee an amount
required to satisfy the required Withholding Taxes as set forth by Internal
Revenue Service guidelines for the employer's minimum statutory withholding with
respect to Grantee pertaining to cash payments under the Award (including any
cash dividends made in respect of the Shares subject to the Award). For purposes
of this Agreement, "Fair Value" means the closing sales price of the Shares on
the New York Stock Exchange on such date, or in the absence of reported sales on
such date, the closing sales price of the Shares on the immediately preceding
date for which sales were reported.

     10. Plan Governs. The Grantee hereby acknowledges receipt of a copy of the
Plan and agrees to be bound by all of the terms and provisions thereof. The
terms of this Agreement are governed by the terms of the Plan, and in the case
of any inconsistency between the terms of this Agreement and the terms of the
Plan, the terms of the Plan shall govern.

     11. Severability. If any provision of this Agreement is, or becomes, or is
deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any
Person or the Award, or would disqualify the Plan or Award under any laws deemed
applicable by the Committee, such provision shall be construed or deemed amended
to conform to the

                                      -4-

<PAGE>

applicable laws, or, if it cannot be construed or deemed amended without, in the
determination of the Committee, materially altering the intent of the Plan or
the Award, such provision shall be stricken as to such jurisdiction, Person or
Award, and the remainder of the Plan and Award shall remain in full force and
effect.

     12. Notices. All notices required to be given under this Grant shall be
deemed to be received if delivered or mailed as provided for herein, to the
parties at the following addresses, or to such other address as either party may
provide in writing from time to time.

To the Company: HCA Inc.
                One Park Plaza
                Nashville, TN 37203
                Attn: Vice President - Compensation

To the Grantee: The address then maintained with respect to the Grantee in the
                Company's records.

     13. Governing Law. The validity, construction and effect of this Agreement
shall be determined in accordance with the laws of the State of Delaware without
giving effect to conflicts of laws principles.

     14. Successors in Interest. This Agreement shall inure to the benefit of
and be binding upon any successor to the Company. This Agreement shall inure to
the benefit of the Grantee's legal representatives. All obligations imposed upon
the Grantee and all rights granted to the Company under this Agreement shall be
binding upon the Grantee's heirs, executors, administrators and successors.

     15. Resolution of Disputes. Any dispute or disagreement which may arise
under, or as a result of, or in any way related to, the interpretation,
construction or application of this Agreement shall be determined by the
Committee. Any determination made hereunder shall be final, binding and
conclusive on the Grantee and the Company for all purposes.

                            [SIGNATURE PAGE FOLLOWS.]

                                      -5-

<PAGE>

     IN WITNESS WHEREOF, the parties have caused this Restricted Share Award
Agreement to be duly executed effective as of the day and year first above
written.

                                        HCA Inc.

                                        By: /s/ Jack O. Bovender, Jr.
                                            ------------------------------------

                                        Grantee:

                                        ----------------------------------------
                                        Please Print

                                        Grantee:

                                        ----------------------------------------
                                        Signature

                                      -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]